Showing 41-60 of 489 for: Cochrane Systematic Reviews > Gastrointestinal 
- Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding
Cochrane Systematic Reviews, 5-Aug-2009
Endoscopic treatment is recommended for initial hemostasis in non-variceal upper gastrointestinal bleeding. Many endoscopic hemostatic devices are used. Argon Plasma Coagulation (APC) is an alternative.
- Aromatherapy for treatment of postoperative nausea and vomiting
Cochrane Systematic Reviews, 10-Mar-2018
Postoperative nausea and vomiting (PONV) is a common, unpleasant phenomenon and current therapies are not always effective for all patients. Aromatherapy has been suggested as an addition to the available treatment strategies. This review was originally p
- Artificial and bioartificial support systems for liver failure
Cochrane Systematic Reviews, 26-Jan-2004
Artificial and bioartificial liver support systems may 'bridge' patients with acute or acute-on-chronic liver failure to liver transplantation or recovery.
- Azathioprine and 6‐mercaptopurine for maintenance of remission in ulcerative colitis
Cochrane Systematic Reviews, 18-May-2016
Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine and 6-mercaptopurine for the maintenance of remission is still controversial.
- Azathioprine for primary biliary cirrhosis
Cochrane Systematic Reviews, 15-Oct-2008
Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting.
- Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 26-Oct-2016
The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was performed to assess the effective
- Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 5-May-2016
The therapeutic role of azathioprine (AZA) and 6-mercaptopurine (6-MP) remains controversial due to their relatively slow onset of action and potential for adverse events. An updated meta-analysis was performed to evaluate the efficacy of these agents for
- Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults
Cochrane Systematic Reviews, 5-Jul-2012
Non-selective beta-blockers are used as a first-line treatment for primary prevention in patients with medium- to high-risk oesophageal varices. The effect of non-selective beta-blockers on mortality is debated and many patients experience adverse events.
- Bariatric surgery for non‐alcoholic steatohepatitis in obese patients
Cochrane Systematic Reviews, 20-Jan-2010
Nonalcoholic fatty liver disease (NAFLD) is increasingly recognised as a condition associated with overweight or obesity that may progress to end-stage liver disease. NAFLD histology resembles alcohol-induced liver injury, but occurs in patients with no h
- Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children
Cochrane Systematic Reviews, 7-Dec-2011
Faecal incontinence is a common and potentially distressing disorder of childhood.
- Bicyclol for chronic hepatitis B
Cochrane Systematic Reviews, 16-Oct-2008
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis B. Until now, systematic reviews of bicyclol therapy have not been performed.
- Bicyclol for chronic hepatitis C
Cochrane Systematic Reviews, 16-Oct-2008
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis C. Until now, systematic reviews on bicyclol therapy have not been performed.
- Bile acids for non‐alcoholic fatty liver disease and/or steatohepatitis
Cochrane Systematic Reviews, 9-Jul-2020
- Bile acids for primary sclerosing cholangitis
Cochrane Systematic Reviews, 19-Jan-2011
Primary sclerosing cholangitis is a progressive chronic cholestatic liver disease that usually leads to the development of cirrhosis. Studies evaluating bile acids in the treatment of primary sclerosing cholangitis have shown a potential benefit of their
- Bile acids for viral hepatitis
Cochrane Systematic Reviews, 17-Oct-2007
Trials have assessed bile acids for patients with viral hepatitis, but no consensus has been reached regarding their usefulness.
- Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults
Cochrane Systematic Reviews, 13-Jun-2012
Faecal incontinence is a particularly embarrassing and distressing condition with significant medical, social and economic implications. Anal sphincter exercises (pelvic floor muscle training) and biofeedback therapy have been used to treat the symptoms o
- Blood transfusion for treating malarial anaemia
Cochrane Systematic Reviews, 25-Oct-1999
Blood transfusion is used in patients with severe malarial anaemia, but risks adverse reactions, transmission of disease, and is complicated to organize in developing countries.
- Branched‐chain amino acids for people with hepatic encephalopathy
Cochrane Systematic Reviews, 18-May-2017
Hepatic encephalopathy is a brain dysfunction with neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting. The severity ranges from minor symptoms to coma. A Cochrane systematic review including 11 randomised
- Budesonide for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 29-May-2015
Corticosteroids are commonly used for the induction of remission in Crohn's disease. However, traditional corticosteroids can cause significant adverse events. Budesonide is an alternative glucocorticoid with limited systemic bioavailability.
- Budesonide for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 21-Aug-2014
Corticosteroids are effective for induction, but not maintenance of remission in Crohn's disease. Significant concerns exist regarding the risk for adverse events, particularly when corticosteroids are used for long treatment courses. Budesonide is a gluc
